Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Biotech Acquisition Company - Class A Ordinary Shares (NQ:BIOT)

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 10.14 (175)
Ask (Size) 10.20 (44)
Prev. Close 10.15
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 8,024,092
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Blade Therapeutics to Participate in “Drug Development in Pulmonary Medicine” Panel Discussion at 2022 BTIG Biotechnology Conference
From Blade Therapeutics, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! We're preparing for another busy day of trading with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace

Performance

More News

Read More
Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference
From Blade Therapeutics, Inc.
Via Business Wire
Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
From Blade Therapeutics, Inc.
Via Business Wire
Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package
From Blade Therapeutics, Inc.
Via Business Wire
Blade Therapeutics to Present Data from Preclinical and Phase 1 Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
From Blade Therapeutics, Inc.
Via Business Wire
Blade Therapeutics Announces Successful Completion of Phase 1 Clinical Study that Evaluated Co-Administration of Cudetaxestat with Either of Two Approved Therapies for Idiopathic Pulmonary Fibrosis
From Blade Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Biotech Acquisition Company - Class A Ordinary Shares publicly traded?
Yes, Biotech Acquisition Company - Class A Ordinary Shares is publicly traded.
What exchange does Biotech Acquisition Company - Class A Ordinary Shares trade on?
Biotech Acquisition Company - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Biotech Acquisition Company - Class A Ordinary Shares?
The ticker symbol for Biotech Acquisition Company - Class A Ordinary Shares is BIOT on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.